Stockreport

Minimal Residual Disease Testing Market Worth $4.45 billion by 2031--Exclusive Report by Meticulous Research® [Yahoo! Finance]

Illumina, Inc.  (ILMN) 
Last illumina, inc. earnings: 4/30 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: illumina.com/company/investor-information.html
PDF Analysis By Offering, Technology (PCR, Flow Cytometry, NGS) Application (Lymphoma, Leukemia, Multiple Myeloma, Solid Tumor) Sample (Blood, Bone Marrow) – Global Forecast [Read more]